This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...